About Us

David Patti

Senior Advisor

David has 20 years of experience providing corporate, product, and pipeline communications leadership to the pharmaceutical and biotech industries.

He has led PR agency teams supporting small to large pharma and biotech organizations, including Aventis (Taxotere), Pfizer (Sutent), Alexion (Soliris), and Helsinn Therapeutics. Corporate communications work includes Head of Communications for Bayer’s Cardiovascular, Renal, and Established Products portfolio; Director of Global Communications for LEO Pharma’s eczema portfolio.

David brings a multi-faceted skillset, having led more than 20 U.S. and Global regulatory approvals; operating as a media spokesperson, media relations strategist, reputation/issues management driver, and patient advocacy and engagement leader for both emerging and established companies.

Therapeutic Focus: Nephrology; Oncology/Hematology; Cardiology; Neurology; Immunology; Metabolic Disease; Urology; Infectious Disease; Rare Disease; Respiratory/Allergy; Dermatology; AI-assisted healthcare.

David’s ability to see things differently enables him to create innovative approaches to opportunities and problem-solving. He firmly believes in the power of translating the science of medicine into compelling stories that influence behavior and encourage action.